Pronexus Analytical is a preclinical contract research organization (CRO) offering advanced services and collaborative projects in CNS pharmacology, neurochemistry and bioanalysis. Pronexus core expertise is focused on PK/PD studies using in vivo microdialysis in experimental models of CNS and metabolic disorders.
The bioanalytical services include UHPLC-MS/MS, high-sensitive HPLC methods, and immunoassays for measuring the levels of neurotransmitters, metabolites, drugs, neuropeptides and proteins in biological samples including microdialysates, cell lysates, CSF, plasma, urine and tissue extracts.